HR 5668 · 116th Congress · Health
MODERN Labeling Act of 2020
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2020-11-18)
Plain Language Summary
[AI summary unavailable — showing source text]
Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020 This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 5668, Making Objective Drug Evidence Revisions for New Labeling Act of 2020
Oct 29, 2020As ordered reported by the House Committee on Energy and Commerce on July 15, 2020
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office